Alopecia aka Hair Loss


The nature of hair loss is essentially genetically determined although there may be associated hormonal or medical conditions that can exacerbate the problem. Anyone can lose hair on the head but it is more common in men. 

There are described 3 types of hair loss:

  • Alopecia areata (patchy baldness)
  • Alopecia totalis (affects all of the head including eyelashes and eyebrows)
  • Alopecia universalis (total body)

Essentially alopecia areata is an autoimmune condition where the immune system attacks healthy hair follicles causing the hair shaft to fall out. While we all normally lose 50-90 hair follicles per day as part of natural loss, anything greater than 100 follicles would be described as pathological. 

The commonest type of areata loss is androgenetic or male pattern baldness. 50% of men and 10% of women will suffer this problem. Genetic causes of hair loss are not purely maternal but are a combination of different family members known as polygenic inheritance.

Alopecia areata is seen and possibly related to autoimmune damage to the hair follicle. The hair follicle may recover with time or may be permanently lost. 

Stem cells used for baldness

The use of stem cells for alopecia is dependent on the nature of the loss and the totality of the baldness.

For example a person presenting with a Norwood hair loss stage 7 would be disappointed with the result of stem cells. This is because the baldness is so profound and the stem cells would not be able to differentiate into hair follicles to ensure satisfaction by the patient. However patients with discrete areas of areata or thinning of the hair would see more pleasing results over 3-12 months since the nature of the stem cells are immunomodulatory and they would be encouraged to differentiate to hair follicles.

Stem cells for alopecia are therefore a long term benefit by preventing thinning and should not be seen as an immediate effect as what one may get with hair transplantation. Even then the results of hair transplantation would also take 3-12 months to see a real benefit.

The reader should also be aware of the research undertaken by Professor Vickers in the field of hair regeneration and activation of the hair follicle by topical applications of a formula of Zinc Thymidine. Indeed Professor Vickers has a worldwide patent on this chemical formula and drug and has been published in a peer reviewed journal. He recommends stem cells to the affected scalp as a restorative and regenerative method to encourage more hair follicles and to use Zinc Thymidine topically. The reader is invited to search for the article and read it themselves via his publications list.


The diagnosis and treatment of alopecia itself can be challenging. It is a major cause of concern by both women and men at mostly the middle years of life. The use of stem cells should be reserved for those patients with thinning or alopecia areata. Prior to consideration of stem cells you would need to undergo the treatment of mini liposuction and IV stem cell injection and infusion.

At we pride ourselves on ensuring patients know the team diagnosing and conducting their stem cell therapy. Professor Russell Vickers is the lead specialist, working within a team of specialist surgeons and doctors.

Important questions that patients should ask of any treating clinicians and facility:

  • Are my treating doctors specialist surgeons/doctors and stem cell experts?
  • How many publications and research based studies have they published in peer reviewed journals?
  • Can they augment stem cell therapy with the known benefits of adjunctive therapy? is Europes premier stem cell organisation guided by evidence based medicine and clinical research.

Our founding director, Professor Russell Vickers PhD, MDsc, M Med, MA, FFPM (ANZCA) is an Australian and New Zealand board registered surgeon with over 100 publications, books and thousands of invited lectures and presentations on stem cells, pain, peptide synthesis and biochemistry. Professor Vickers is the leader of a family team of surgeons assisting him including Dr Peter Vickers, MD, FRCS (Edinburgh), FRACDS, Dr Richard Vickers, MD, FRCS (England, Glasgow, Ireland), FRACDS (OMS) and Dr Jessica Vickers, MD, MCOM, BA/BN as co-ordinator.

This medical summary has been written by Professor Vickers and his family team of specialist consultants.

It has been written by medically qualified writers.

Other Diseases We Treat


Pathology: Dementia is a condition characterised by progressive or persistent loss of intellectual functioning, especially with impairment of memory and abstract Continue Reading

Read More

Headache and Migraine

Pathology:  A headache is any pain in the head, behind the eyes and above the ears. It may be described as Continue Reading

Read More

Cosmetic Stem Cells for the Face

Pathology:  Facial structure undergoes the ageing process like all tissues. The structure is composed of bone and soft tissue which Continue Reading

Read More



Get an online consultation with one of our doctors that specialize in stem cell therapy to help you assess if this type of treatment can help with your condition